Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueGross ProfitLeasesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsPreferred Shares IssuedProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares OutstandingShares Outstanding
Ratios

DarioHealth (DRIO) Shares Outstanding (2016 - 2025)

DarioHealth filings provide 14 years of Shares Outstanding readings, the most recent being $6.9 million for Q4 2025.

  • On a quarterly basis, Shares Outstanding rose 259.79% to $6.9 million in Q4 2025 year-over-year; TTM through Dec 2025 was $6.9 million, a 259.79% increase, with the full-year FY2025 number at $6.9 million, up 259.79% from a year prior.
  • Shares Outstanding hit $6.9 million in Q4 2025 for DarioHealth, up from $6.8 million in the prior quarter.
  • In the past five years, Shares Outstanding ranged from a high of $42.7 million in Q1 2025 to a low of $9912.0 in Q3 2022.
  • Median Shares Outstanding over the past 5 years was $2.1 million (2024), compared with a mean of $10.1 million.
  • Biggest five-year swings in Shares Outstanding: crashed 99.98% in 2023 and later soared 827556.45% in 2024.
  • DarioHealth's Shares Outstanding stood at $16.6 million in 2021, then soared by 55.22% to $25.7 million in 2022, then plummeted by 94.71% to $1.4 million in 2023, then surged by 41.18% to $1.9 million in 2024, then soared by 259.79% to $6.9 million in 2025.
  • The last three reported values for Shares Outstanding were $6.9 million (Q4 2025), $6.8 million (Q3 2025), and $2.3 million (Q2 2025) per Business Quant data.